| Authors: |
Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA., Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA., Robertson JS; Independent Adviser, United Kingdom., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Gurwith M; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA., Monath TP; Crozet BioPharma LLC, Devens, MA 01434, USA., Pavlakis G; National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA., Fast PE; International AIDS Vaccine Initiative, New York, NY 10004, USA; Stanford School of Medicine, Palo Alto, CA 94305, USA., Smith J; VLP Therapeutics, Gaithersburg, MD 20878, USA., Smith ER; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA., Chen RT; Brighton Collaboration, a Program of the Task Force for Global Health, Decatur, GA, USA., Kochhar S; Global Healthcare Consulting, New Delhi, India; University of Washington, Seattle, WA 98195, USA. |